Is Vorapaxar a safe and effective antiplatelet agent for patients with prior ischaemic stroke receiving standard antiplatelet therapy? | J Pak Med Assoc;64(6): 719, 2014 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Is Vorapaxar a safe and effective antiplatelet agent for patients with prior ischaemic stroke receiving standard antiplatelet therapy?

Aftab, Kiran; Kamal, Ayeesha Kamran.

J Pak Med Assoc ; 64(6): 719, 2014 Jun.

Article in En | MEDLINE | ID: mdl-25252501

Subject(s)

Intracranial Hemorrhages/epidemiology; Lactones/adverse effects; Lactones/therapeutic use; Platelet Aggregation Inhibitors/adverse effects; Platelet Aggregation Inhibitors/therapeutic use; Pyridines/adverse effects; Pyridines/therapeutic use; Stroke/drug therapy; Female; Humans; Male

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Platelet Aggregation Inhibitors / Stroke / Intracranial Hemorrhages / Lactones Limits: Female / Humans / Male Language: En Journal: J Pak Med Assoc Year: 2014 Document type: Article

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Platelet Aggregation Inhibitors / Stroke / Intracranial Hemorrhages / Lactones Limits: Female / Humans / Male Language: En Journal: J Pak Med Assoc Year: 2014 Document type: Article